DEA Archived Press Releases

Press Releases before January 20, 2025
406 Results - Showing 361 to 370
PRESS RELEASE

Judge sentences St. Louis County doctor for fraudulently obtaining opioid narcotic prescription drugs

ST. LOUIS – United States District Court Judge Rodney W. Sippel sentenced today Angela K. Williams, M.D., to three years’ probation, $745 in restitution to Medicare and Medicaid and 100 hours community service today. The 34-year-old Brentwood, Missouri, resident pleaded guilty in January to fraudulently obtaining oxycodone. According to the...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

Former Long Island Doctor Pleads Guilty to conspiring to illegally distribute oxycodone

BROOKLYN, N.Y. - Earlier today, in federal court in Central Islip, Tameshwar Ammar, a former medical doctor in Roslyn, New York, pleaded guilty via teleconference to conspiring to illegally distribute oxycodone. Ammar was indicted in November 2019. On June 22, 2020, he relinquished his license to practice medicine. Today’s plea...
PRESS RELEASE

Doctor Pleads Guilty In Manhattan Federal Court To Illegal Distribution of Oxycodone From Brooklyn Clinic

NEW YORK - Today, Ray Donovan, Special Agent in Charge of the New York Field Division of the Drug Enforcement Administration (“DEA”), Audrey Strauss, the Acting United States Attorney for the Southern District of New York, Leigh-Alistair Barzey, Special Agent in Charge of the Northeast Field Office of the U.S...
PRESS RELEASE

Buffalo woman sentenced for allowing her former boyfriend to write fraudulent prescriptions for Adderall

BUFFALO, N.Y. – Drug Enforcement Administration, New York Division, Special Agent in Charge Ray Donovan, and Western District of New York, U.S. Attorney James P. Kennedy, Jr., announced today that Phousavath Luangrath, 30, of Buffalo, NY, who was convicted of misprision of a felony, was sentenced to serve one year...
PRESS RELEASE

Retired Cadott, Wisconsin physician to pay $70,000 to resolve controlled substances prescribing, recordkeeping violations

MADISON, Wis. – The Drug Enforcement Administration Special Agent in Charge Robert J. Bell of the Chicago Field Division, and the United States Attorney Scott C. Blader announced that Clifford T. Bowe, M.D., a retired Cadott, Wisconsin physician, entered into a settlement agreement to pay $70,000 to resolve civil allegations...
PRESS RELEASE

Dallas Doctor Pleads Guilty to Prescription Drug Diversion Scheme on Elderly

DALLAS - A Dallas doctor has pleaded guilty to a felony for prescription drug diversion crimes perpetrated on elderly victims, announced Eduardo A. Chavez, Special Agent in Charge of the DEA Dallas Field Division and U.S. Attorney Erin Nealy Cox. Dr. Edward Agura, 63, pleaded guilty before U.S. Magistrate Judge...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
PRESS RELEASE

Omnicare agrees to pay over $15 Million to resolve allegations it improperly dispensed opioids at long-term care facilities

PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...